Le Bonheur Children's Hospital

Summary

Le Bonheur Children's Hospital is a medical facility located in Memphis, Tennessee. This center is recognized for care of Epilepsy, Seizures, Myoclonic Astatic Epilepsy, Dravet Syndrome, Partial Cycloplegia and other specialties. Le Bonheur Children's Hospital is involved with conducting 102 clinical trials across 178 conditions. There are 7 research doctors associated with this hospital, such as James Wheless, MD, John Eshun, MD, Ali M Onder, MD, and Umar S Boston, MD.

Top PIs

Clinical Trials running at Le Bonheur Children's Hospital

Epilepsy

Seizures

Patent Ductus Arteriosus

Partial Cycloplegia

Myoclonic Astatic Epilepsy

Dravet Syndrome

Migraine

Hemorrhagic Shock

Neurodevelopmental Disorder

Bronchopulmonary Dysplasia

Cenobamate

for Epilepsy

Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures

Recruiting

2 awards

Phase 3

12 criteria

LP352

for Epilepsy

This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration period, Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 24 months.

Recruiting

1 award

Phase 3

3 criteria

LP352

for Dravet Syndrome

This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DS. The study consists of 3 main phases: Screening, Titration period, and Maintenance period, followed by a Taper period and Follow-Up. Participants will be randomized to LP352 or placebo. The total duration of the study will be approximately 24 months.

Recruiting

1 award

Phase 3

1 criteria